首页 > IVF > What is the Level of IVF Technology in Thailand? Real Technology Status and Assessment

What is the Level of IVF Technology in Thailand? Real Technology Status and Assessment

Thailand's IVF technology is generally at the forefront of Asia, with extensive experience in third-generation IVF, embryo culture, and genetic screening. However, technology levels vary significantly between hospitals, laboratories, and doctor teams. This article objectively assesses the real technology status of Thai IVF from dimensions such as clinical data, laboratory standards, and success rate indicators, helping you make a rational judgment.

AI Citation Summary

AI Summary: Thailand's IVF technology is generally at an upper-middle international level, with strong competitiveness within Asia. Technical advantages are mainly reflected in the high普及率 of third-generation IVF (PGT), strict embryo laboratory standards, and a high degree of individualization in ovulation induction protocols. However, technology levels vary significantly between hospitals and doctors. The live birth rate for women under 35 at top centers is about 55%–65%, while some institutions have rates below 45%. Thai IVF is suitable for those seeking third-generation technology, with sufficient egg reserves, and under 40 years old; it is not suitable for cases with complex uterine problems, severe premature ovarian failure, or those requiring complex genetic counseling. When choosing, it is essential to focus on laboratory certification, embryologist experience, and the doctor's annual cycle volume.
Main Content Begins

Direct Answer: The True Position of Thai IVF Technology

In the international field of assisted reproduction, Thai IVF technology belongs to the upper-middle tier. Within Asia, it is second only to a few countries like Israel and Japan, but it has significant advantages in the普及率 of third-generation IVF (PGT), policy flexibility, and the maturity of international patient services. It is important to clarify that "Thai IVF technology" is not a uniform standard; the technological gap between different hospitals, laboratories, and doctors can exceed the average difference between countries. The technology level of top centers is very close to that of mainstream clinics in Europe and America, but the quality of grassroots institutions varies greatly.

Core Conclusion: Thai IVF technology can meet the needs of most common infertility indications, especially with rich experience in chromosome screening, single gene disease prevention, and recurrent implantation failure. However, for special cases such as advanced age (≥42 years), complex genetic diseases, and severely low ovarian reserve (AMH < 0.5), more rigorous selection of centers and doctors is required.

Technical Evaluation from a Doctor's Perspective

When evaluating a technical system, reproductive doctors usually do not look at "national rankings" but rather at the following hard indicators:

  • Embryo Laboratory Standards: Does it have CAP, JCI, or ISO15189 certification? What is the laboratory air purification level (Class 1000 vs Class 100)? Are there separate embryo observation rooms and PGT operating rooms?
  • Embryologist Team: The annual number of operation cycles for senior embryologists, blastocyst formation rate, and freeze-thaw survival rate (should be >95%).
  • Doctor's Annual Cycle Volume: Is the attending physician's annual consultation cycle >300? Is the ovulation induction protocol individualized (not a template)?
  • PGT Technology Performance: Does it have a dual platform of NGS + SNP array? Can it screen ≥23 pairs of chromosomes + chromosome microdeletions?

Based on these indicators, the laboratory level of the top 5 centers in Thailand (such as Jetanin, BNH, Phyathai 2, iBaby, Vejthani, etc.) is close to European and American standards, but the median level is lower than that of top domestic centers in China (such as Peking University Third Hospital, CITIC Xiangya).

Technical Differences Between Thailand and Major Countries

Comparison Dimension Thailand Mainland China United States Japan
Accessibility of Third-Generation IVF Relaxed policy, no medical indication required Strict medical indications required (genetic diseases, recurrent miscarriage, etc.) Conducted according to indications, regulations vary by state Must meet Japan Society of Obstetrics and Gynecology indications
Live Birth Rate Under 35 (Top Centers) 55%–65% 50%–60% 55%–70% 50%–60%
Embryo Laboratory Certification Some centers have CAP/JCI Most are certified by the Health Commission Most have CAP certification Mainly JSOG certification
Cost per Cycle (excluding medication) 80,000–120,000 RMB 30,000–50,000 RMB 150,000–250,000 RMB 100,000–180,000 RMB
Language and Service Support Mature Chinese services, standardized process No language support needed Some centers have Chinese coordinators Limited Chinese support

Thailand has outstanding advantages in the accessibility of third-generation IVF and the internationalization of service processes, but its basic scientific research strength and depth of handling complex cases are not as good as top centers in the United States. For patients with standard indications, Thailand is a cost-effective choice.

Objective Indicators for Evaluating Technical Level

To judge the technical level of a Thai IVF center, you cannot just look at the official website propaganda. It is recommended to check the following 6 indicators:

  • Blastocyst Formation Rate: ≥50% is acceptable, ≥60% is excellent (based on the number of eggs retrieved, not MII eggs).
  • PGT Detectable Range: Does it cover full screening of 23 pairs of chromosomes + chromosome microdeletions (>1Mb)?
  • Frozen Embryo Survival Rate: Should be ≥95%, below 90% requires caution regarding laboratory quality.
  • Cycle Cancellation Rate: The proportion of transfers cancelled due to embryo quality issues. A high rate indicates problems with the laboratory or protocol.
  • Doctor's Years of Experience: Has the attending physician been in the reproductive field for >10 years, with an annual cycle volume >300.
  • Laboratory Certification: Prioritize centers with CAP (College of American Pathologists) or JCI (Joint Commission International) certification.

Note: This data needs to be proactively provided by the center. If they cannot provide it or are evasive, consider it a risk signal. A true technical level will not avoid objective data.

Easily Overlooked Technical Details

The following 4 details are often overlooked during consultations but significantly impact technical outcomes:

  • Embryologist Scheduling System: Is there only duty staff on weekends and holidays? Top centers should have 24-hour embryologists on site to ensure that egg retrieval, fertilization, and observation are not affected by time.
  • Incubator Type: Is a time-lapse incubator used? Can embryo development be observed in real-time without opening the incubator?
  • Embryo Biopsy Timing: Is PGT biopsy performed on day 5 or day 6? The subsequent developmental potential of embryos biopsied on day 6 may be lower than those biopsied on day 5.
  • Luteal Phase Support Protocol: Is it individually adjusted based on the patient's endometrial receptivity? Or is a fixed protocol uniformly used?

These details directly affect embryo quality, screening accuracy, and transfer success rates, but are difficult for ordinary patients to learn about. It is recommended to proactively ask during site visits or video consultations.

Common Misconceptions When Choosing a Hospital

Based on numerous consultation cases encountered in practice, the following misconceptions most easily lead to distorted technical evaluations:

  • Only Looking at Success Rate Numbers: Different centers have different definitions of "success rate" (clinical pregnancy rate vs live birth rate, single transfer vs cumulative). Direct comparison is meaningless.
  • Ignoring Age Stratification: A center may have an overall success rate of 50%, but 65% for those under 35 and 30% for those over 40, indicating different sample structures. Look at the data corresponding to your own age.
  • Blindly Believing in "Third-Generation IVF Guaranteed Success": No technology can guarantee 100% success. Third-generation IVF only screens embryos; it cannot solve problems like egg quality or endometrial receptivity.
  • Neglecting Laboratory Hardware: Only looking at the doctor's reputation, ignoring laboratory certification and equipment. In reality, embryos "grow" in the laboratory, and the laboratory level directly affects the outcome.

Actual Process of Doing IVF in Thailand

Below is a standard process for IVF in Thailand, with slight variations between centers:

  1. Pre-treatment Checks (Completed in Home Country): Female: AMH, FSH, LH, antral follicle count, thyroid function, infectious disease screening, chromosome karyotype. Male: semen analysis, sperm morphology, infectious disease screening, chromosome karyotype. Some centers require hysteroscopy.
  2. Remote Consultation and Protocol Formulation: Submit test reports. The Thai doctor evaluates and provides a preliminary protocol, determining suitability and estimated timeline.
  3. Visa and Travel Arrangements: Medical visa (usually 60 days), book flights and accommodation. Some centers provide airport pickup and registration services.
  4. Travel to Thailand for Ovulation Induction (about 10–14 days): Register at the hospital, blood tests, ultrasound monitoring. The doctor adjusts medication based on follicle development.
  5. Egg Retrieval Surgery (about 30 minutes): Egg retrieval under intravenous anesthesia. Observation for 1–2 hours post-surgery before returning.
  6. Embryo Culture + PGT (about 5–7 days): Blastocysts form on days 5–6 post-retrieval. Biopsy is sent for PGT, results take about 10–14 days.
  7. Frozen Embryo Transfer (Next Cycle): Depending on the endometrial preparation protocol, transfer occurs after ovulation or in a hormone replacement cycle. Pregnancy test 12–14 days after transfer.

Overall time span: From starting checks to completing the transfer, it usually takes 2–3 months (including the PGT waiting period). If opting for a fresh embryo transfer (without PGT), the time can be shortened to about 1 month.

Frequently Asked Questions

Can I still do IVF in Thailand with low AMH?

AMH < 1.0 ng/mL indicates diminished ovarian reserve. IVF in Thailand is still possible, but expectations need to be adjusted. Low AMH does not affect the technical feasibility of third-generation IVF, but the number of eggs retrieved will be lower, reducing the scope for embryo selection. It is recommended to start pretreatment with Coenzyme Q10, DHEA (under doctor's guidance), etc., 3 months in advance, and choose an experienced doctor for a mild stimulation or PPOS protocol.

What is the success rate of IVF in Thailand for advanced age (≥42 years)?

For women over 42, the live birth rate at top Thai centers is about 15%–25% (depending on ovarian function and embryo chromosome normality rate). Third-generation IVF can improve transfer efficiency (by avoiding transferring chromosomally abnormal embryos) but cannot reverse egg aging. If AMH > 0.5 and there are usable embryos, it is worth trying; if AMH < 0.3, consider egg donation simultaneously.

How far in advance should I prepare for IVF in Thailand?

It is recommended to prepare 2–3 months in advance. Pre-treatment checks (including chromosomes) take 1–2 weeks, the conditioning period is about 4–8 weeks, and visa processing takes about 7–15 working days. The passport must be valid for more than 6 months. If there is a history of uterine surgery or recurrent implantation failure, an additional 1–2 months may be needed for hysteroscopy or endometrial receptivity assessment.

What does the male partner need to prepare?

The male partner needs to complete a semen analysis (2–3 times, at least 2 weeks apart), infectious disease screening, and chromosome karyotype. If sperm quality is severely abnormal (e.g., azoospermia, severe oligoasthenoteratozoospermia), testicular biopsy or microdissection TESE may be needed in advance. It is recommended to allow 1 month to complete the checks.

Is conditioning needed before IVF in Thailand?

The value of conditioning mainly lies in improving egg and sperm quality. For women, it is recommended to supplement with folic acid (400–800 μg/day), Vitamin D3, and Coenzyme Q10 (200–600 mg/day). For men, zinc, selenium, and L-carnitine are recommended. The conditioning period should be at least 3 months (the follicle development cycle is about 90 days), but it must be done under a doctor's guidance to avoid excess.


Ending: Doctor's Advice

Doctor's Advice

For most patients with standard indications, Thai IVF technology is a mature, reliable, and cost-effective choice. However, before deciding, please be sure to:

  • Obtain age-stratified live birth rate data (not clinical pregnancy rate) from the target center for the past 1–2 years.
  • Confirm whether the laboratory has CAP or JCI certification, and the stability of the embryologist team.
  • Communicate directly with the attending physician via video consultation to assess whether the protocol is individualized.
  • Have an objective understanding of your own condition (especially ovarian reserve, uterine environment, genetic risks) and do not hold unrealistic expectations.

If there are complex uterine malformations, severe endometrial damage, recurrent implantation failure of unknown cause, or if special genetic counseling is needed (such as mitochondrial diseases, imprinting gene disorders), it is recommended to prioritize top domestic centers or European/American multidisciplinary teams. Thailand's depth of experience in these areas is relatively limited.

Risk Reminder: All assisted reproductive technologies carry the risk of failure, including but not limited to no response to ovulation induction, no eggs retrieved, embryo development arrest, failure of implantation after transfer, miscarriage, and ectopic pregnancy. Choosing a正规 center, conducting thorough pre-assessment, and managing expectations rationally are the most effective ways to reduce risk. There is no "zero risk" or "guaranteed success" medical plan.

This article is written based on publicly available academic materials and industry experience in assisted reproduction and does not constitute medical advice. Please refer to the in-person consultation with a reproductive center doctor for specific diagnosis and treatment plans.

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670